高级别胶质瘤部分脑放疗期间海马弥散周变化与剂量及早期记忆改变的关系
海马ADC从第1周中位相对变化0.5%增至第6周12%,每周+2.2个百分点(95%CI 1.8-2.5;P<0.001);校正周次后,计划双侧海马平均剂量越高ADC变化越大(+0.81百分点/Gy;95%CI 0.76-0.93;P<0.001)。
要点
- 部分脑放疗期间海马ADC呈进行性升高,第6周中位相对变化达12%。
- 计划海马剂量越高,ADC变化幅度越大,同侧与对侧海马均显示剂量关联。
- 海马ADC可作为治疗期候选影像表型,尚需前瞻性验证。
核心结论
- 分次部分脑放疗期间每周弥散MRI显示海马ADC进行性升高,且变化幅度与计划海马剂量相关。
研究设计与样本
- 放疗前及治疗期间每周行弥散MRI,纵向评估双侧海马相对ADC变化与FA。
- 线性混合效应模型以治疗周次和计划双侧海马平均剂量为固定主效应。
主要发现
- 海马ADC从第1周中位相对变化0.5%增至第6周12%(IQR 6%-18%)。
- ADC时间系数为每周+2.2个百分点(95%CI 1.8-2.5;P<0.001)。
- 校正周次后,计划双侧海马平均剂量越高ADC变化越大(+0.81百分点/Gy;95%CI 0.76-0.93;P<0.001)。
- 第6周ADC变化与剂量在同侧海马(β=0.83百分点/Gy;95%CI 0.52-1.26;P=0.013)和对侧海马(β=0.36百分点/Gy;95%CI 0.05-0.712;P=0.046)均相关。
- FA在第3周前保持稳定,第4-6周下降。
临床怎么用
- 治疗期间每周海马弥散MRI可无创监测放疗相关海马反应,ADC变化与计划剂量相关。
- 海马ADC可作为治疗期候选影像表型,用于后续前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the weekly trajectory of hippocampal diffusion during fractionated partial-brain radiation therapy (RT) for high-grade glioma and determine whether the magnitude of change is associated with planned hippocampal dose. METHODS: Forty-five adults enrolled in a prospective observational imaging study and treated with 60 Gy in 30 fractions with concurrent temozolomide underwent diffusion MRI before RT and weekly during treatment. Relative bilateral hippocampal apparent diffusion coefficient (ADC) change and fractional anisotropy (FA) were evaluated longitudinally. Linear mixed-effects models included treatment week and planned mean bilateral hippocampal dose as fixed main effects. A secondary laterally-specific analysis evaluated baseline-to-Week-6 ADC change separately in the hippocampi ipsilateral and contralateral to the tumor. RESULTS: Hippocampal ADC increased progressively from a median relative change of 0.5% at Week 1 to 12% (IQR, 6%-18%) at Week 6. The ADC time coefficient was + 2.2% points per week (95% CI, 1.8-2.5; P < 0.001). After accounting for week, higher planned mean bilateral hippocampal dose was associated with greater ADC change (+ 0.81% points/Gy; 95% CI, 0.76-0.93; P < 0.001). In the secondary laterally-specific analysis, higher dose was associated with greater Week-6 ADC change in both the ipsilateral hippocampus (β = 0.83% points/Gy; 95% CI, 0.52-1.26; P = 0.013) and the contralateral hippocampus (β = 0.36% points/Gy; 95% CI, 0.05-0.712; P = 0.046). FA remained stable through Week 3 and declined during Weeks 4-6. CONCLUSION: Weekly diffusion MRI demonstrates a progressive, dose-associated hippocampal response during fractionated RT. The laterality-specific findings further support an association between local radiation exposure and ADC change and support hippocampal ADC as a candidate treatment-phase imaging phenotype for prospective validation.
引用
- Haisraely O, Panthi B, Noll KR, et al. Weekly hippocampal diffusion changes during partial-brain radiation therapy for high-grade glioma: associations with dose and early memory change. J Neurooncol. 2026. PMID: 42867757. doi:10.1007/s11060-026-05822-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。